查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929541

分支型胸主動脈血管支架市場（按產品類型、器械類型、移植物材料、輸送方式、應用和最終用戶分類），全球預測，2026-2032年

Branched Thoracic Stent Grafts Market by Product Type, Device Type, Graft Material, Delivery Mode, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年分支胸主動脈血管支架市場價值為 4.4121 億美元，預計到 2026 年將成長至 4.7686 億美元，預計到 2032 年將達到 6.8593 億美元，複合年成長率為 6.50%。

主要市場統計數據
基準年 2025 4.4121億美元
預計年份：2026年 4.7686億美元
預測年份：2032年 6.8593億美元
複合年成長率 (%) 6.50%

本文簡要概述了分支型胸主動脈血管支架創新技術如何改變手術選擇、臨床工作流程和醫療設施規劃。

分支型胸血管支架透過微創、標靶修復主動脈弓及其下游血管，正在重塑複雜主動脈病變的臨床治療模式。器械設計、影像導引部署和輸送系統的改進，已使許多手術從開放式手術轉向血管內或混合治療。這一發展體現了技術創新與臨床需求的融合。臨床醫生正在尋求能夠減少手術全期併發症、縮短恢復時間，同時維持分支血管通暢性和長期主動脈完整性的解決方案。

臨床證據的不斷增加、技術轉型、監管機構對真實世界數據的重視以及供應鏈的韌性等因素，是如何改變血管支架這種兩極分化的格局的？

分支型胸主動脈血管支架市場格局正經歷變革性變化，其驅動力包括技術的成熟、臨床實踐的改變以及臨床醫生期望的提升。器械的改進已不再局限於漸進式提升，而是催生了一系列新的手術方案，以應對複雜的主動脈弓解剖結構並提高手術精準度。這些技術主導的變革，加上越來越多的真實世界證據所證實的良好安全性和令人鼓舞的中期療效，使得越來越多的臨床醫生認知到，血管內修復是開放手術以外的可行選擇。

檢驗了2025年關稅變化對供應鏈、籌資策略和購買行為的實際、商業和營運影響。

影響關稅和貿易的政策趨勢會對從事分叉胸主動脈血管支架生產和分銷的企業的營運和商業決策產生重大影響。 2025年生效的關稅調整為進口組件、成品器械以及手術中常用的專用影像設備帶來了新的成本波動。依賴跨境供應鏈獲取原料、組件（如鞘套和輸送模組）或專用聚合物化合物的製造商，面臨著到岸成本的變化，這些變化已波及到價格談判、供應商選擇和庫存策略等各個方面。

將移植體結構、材料科學、臨床適應症、臨床環境、年齡層和手術方式與決策聯繫起來的全面見解

此細分涵蓋器材配置、材料科學、臨床適應症、醫療機構、患者群體和發行策略，從而提供系統性的觀點來解讀市場動態和臨床決定因素。根據器械類型，此細分市場分為四叉、三叉和二元移植物配置，每種配置都針對不同的解剖結構和手術複雜性。四叉器械適用於需要進行多分支血管重建的全面弓部重組病患。而三叉和二叉設計則用於簡化輸送、縮短手術時間，同時保留或繞過特定弓部血管的情況。

臨床能力、監管管道、採購模式和製造生態系統的區域差異會影響產品應用和商業化策略。

區域差異將從根本上影響分支型胸主動脈血管支架的採用模式、監管參與和商業策略。在美洲，先進的三級醫療中心的臨床團隊率先採用了分支型技術，多學科團隊推動了手術流程和結果報告的改進。對影像基礎設施和混合手術室的投資使複雜病例集中在高容量中心進行處理，而培訓系統、統一的報銷制度和可靠的供應鏈對於更廣泛的應用至關重要。區域法規環境和支付環境將影響器材的上市時間以及醫院對新器材平台的投資意願。

創新和成熟設備製造商的策略競爭策略結合了技術進步、證據累積和適應性商業模式。

分支型胸主動脈血管支架的競爭格局呈現出多元化的特點，既有專業創新型企業，也有成熟的血管器械領導者，還有新興的區域性製造商。主要企業透過專注於器械工程的投資來脫穎而出，例如低輪廓輸送系統、預插管分支導管以及可適應患者個體解剖結構的模組化架構。許多主要參與企業也投入資源，透過建立臨床夥伴關係和註冊登記合作來累積上市後證據，以展示不同臨床環境下的治療效果。

製造商和醫療保健提供者可以採取哪些切實可行的策略步驟來推動設備創新、確保供應連續性並加速在所有醫療保健機構中的臨床應用？

產業領導者應採取整合產品開發、臨床夥伴關係和商業性執行的策略，以加速負責任的推廣應用，同時保障利潤率和業務永續營運。應優先投資於改進設備設計，以降低設備體積和操作複雜性。這些優勢將顯著擴大目標臨床患者群體，並促進其在多種醫療機構中的廣泛應用。除了技術改進之外，還應實施完善的臨床醫生培訓計劃和基於模擬的課程，以配合技術改進，縮短學習曲線，降低併發症發生率，從而增強推廣應用的臨床和經濟合理性。

我們採用混合調查方法，結合專家訪談、臨床文獻綜述和監管評估，為決策者提供可操作的見解。

本分析所依據的研究採用了混合方法，結合了對關鍵行業專家、設備工程師和採購專業人員的定性訪談，以及對同行評審的臨床文獻、手術註冊數據和監管指導文件的二次審查。主要資料收集包括對血管外科醫生、介入放射科醫生和醫院管理人員的結構化訪談，以了解手術偏好、實施障礙和培訓需求。對製造和供應鏈專業人員的技術訪談則為評估材料選擇、組件採購和生產規模化提供了資訊。

對證據、營運準備和適應策略如何決定分支胸主動脈血管支架的長期整合和價值實現的最終見解

分支型胸主動脈血管支架是治療複雜主動脈疾病的一項突破性進展，它為開放性手術提供了一種微創替代方案，同時拓展了解剖結構複雜病例的治療選擇。器材創新、影像導航技術的進步以及臨床經驗的積累，共同推動了手術模式和醫療機構策略的轉變。然而，要使這項技術得到廣泛應用，必須有可證實的療效、可複製的培訓流程以及穩定的供應鏈，這些因素都有助於增強臨床醫生的信心並獲得支付方的認可。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 分支型胸主動脈血管支架市場（依產品類型分類）

  • 預製分支胸主動脈血管支架
  • 患者特異性分叉胸主動脈血管支架
  • 模組化配電系統
  • 混合分枝和窗孔結構

第9章 依器械類型分類的分支型胸主動脈血管支架市場

  • 四岔路
  • 三分支型
  • 分叉型

第10章 依移植物材料分類的分支型胸主動脈血管支架市場

  • 聚酯纖維
  • 乙胺類藥物

第11章 以輸送方式分類的分支型胸主動脈血管支架市場

  • 血管內治療
  • 混合

第12章 分支型胸主動脈血管支架市場（依應用領域分類）

  • 主動脈瘤
    • 胸主動脈瘤
    • 腹部主動脈血管瘤
  • 主動脈剝離
    • A型
    • B型

第13章 分支型胸主動脈血管支架市場（依最終用戶分類）

  • 門診手術中心
    • 醫院所有
    • 獨立的
  • 醫院
    • 私人的
    • 民眾
  • 專科診所

第14章 分支型胸主動脈血管支架市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 分支型胸主動脈血管支架市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國分支型胸主動脈血管支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 美國分支胸主動脈血管支架市場

第17章：中國分支型胸主動脈血管支架市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AorTech International PLC
  • Aptus Endosystems, Inc.
  • Atrium Medical Corporation
  • Bolton Medical, Inc.
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cook Vascular
  • CryoLife, Inc.
  • Endospan Ltd.
  • Endovascular Solutions, Inc.
  • Getinge AB
  • Hemoteq AG
  • Innovative Cardiovascular Solutions, Inc.
  • InspireMD Ltd.
  • Jotec GmbH
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Pulsar Vascular Ltd.
  • Terumo Corporation
  • Vascutek Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-0A3806951806

The Branched Thoracic Stent Grafts Market was valued at USD 441.21 million in 2025 and is projected to grow to USD 476.86 million in 2026, with a CAGR of 6.50%, reaching USD 685.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 441.21 million
Estimated Year [2026] USD 476.86 million
Forecast Year [2032] USD 685.93 million
CAGR (%) 6.50%

A concise orientation to how branched thoracic stent graft innovations are transforming procedural choices, clinical workflows, and institutional planning

Branched thoracic stent grafts are reshaping the clinical approach to complex aortic pathology by enabling less invasive targeted repair of the aortic arch and downstream vessels. Advances in device architecture, imaging-guided deployment, and delivery system refinements have moved many procedures from open surgical repair toward endovascular or hybrid pathways. This evolution reflects a convergence of engineering innovation and clinical demand: clinicians seek solutions that reduce perioperative morbidity and shorten recovery times while preserving branch vessel patency and long-term aortic integrity.

Contemporary devices incorporate features such as pre-cannulated branches, modular configurations, and low-profile sheaths designed to navigate tortuous anatomy. Parallel enhancements in computed tomography angiography, fusion imaging, and intravascular navigation systems have improved pre-procedure planning and intra-procedural accuracy, increasing clinician confidence in treating anatomically challenging cases. As evidence accumulates from registry data and growing clinical series, indications and techniques continue to expand, prompting hospitals, specialty clinics, and ambulatory surgery centers to re-evaluate procedural pathways, capital allocation, and team competencies.

Moreover, the interplay between graft material selection and long-term durability has gained prominence among vascular surgeons and device engineers. Material choice influences graft conformability, suture-line integrity in hybrid procedures, and thrombogenic profile. The device ecosystem now encompasses institutional stakeholders from imaging specialists and perfusion teams to post-anesthesia care units, each influencing adoption and outcomes. Consequently, strategic decisions around investment in branched thoracic stent graft capabilities must account for clinical evidence, operational readiness, and the shifting reimbursement environment that governs procedure selection.

How converging clinical evidence, procedural migration, regulatory emphasis on real-world data, and supply chain resilience are reshaping the branched stent graft landscape

The landscape for branched thoracic stent grafts is undergoing transformative shifts driven by technological maturation, changing care settings, and evolving clinician expectations. Device refinements have progressed beyond incremental improvements to enable a new class of procedures that address complex aortic arch anatomy with improved precision. These technology-led changes are paired with a growing body of real-world evidence demonstrating acceptable safety profiles and encouraging mid-term outcomes, which in turn expands the pool of clinicians who view endovascular repair as a viable alternative to open surgery.

Simultaneously, procedural migration toward less invasive pathways has influenced the distribution of cases across care settings. Ambulatory surgery centers and specialty clinics, particularly those integrated with hospital systems, are increasingly considered for lower-complexity endovascular interventions, while high-acuity or hybrid cases remain concentrated in tertiary hospitals with multidisciplinary teams. This fragmentation of care delivery creates opportunities for device manufacturers to tailor training, delivery profiles, and service models to distinct end-user segments.

Regulatory pathways and post-market surveillance expectations are also shifting. Authorities are placing a stronger emphasis on long-term performance data and real-world evidence generation, prompting manufacturers to invest in registries, procedural training programs, and collaborative research with high-volume centers. Finally, supply chain resilience and component standardization have emerged as pragmatic priorities; scalable manufacturing approaches and strategic supplier partnerships are now integral to sustaining device availability across diverse geographies and care settings. Collectively, these shifts signal a transition from experimental adoption toward mainstream clinical integration contingent on evidence, operational readiness, and stakeholder alignment.

Examining the practical commercial and operational consequences of United States tariff changes in 2025 on supply chains, sourcing strategies, and procurement behavior

Policy developments affecting tariffs and trade can materially influence the operational and commercial calculus for companies involved in branched thoracic stent graft manufacturing and distribution. Tariff adjustments enacted within the United States in 2025 introduced new cost dynamics across imported components, finished devices, and specialized imaging equipment often used in these procedures. Manufacturers that rely on cross-border supply chains for raw materials, components such as sheaths and delivery modules, or specialized polymer compounds encountered changes in landed costs that reverberated through pricing negotiations, vendor selection, and inventory strategies.

In response, several manufacturers implemented mitigation tactics including nearshoring of production, diversification of supplier bases, and renegotiation of long-term procurement contracts to stabilize input costs. Clinical service providers adjusted procurement timelines and engaged in more rigorous cost-benefit assessments when selecting device configurations or opting for single-use versus reusable ancillary equipment. Larger integrated health systems leveraged scale to absorb incremental costs, while smaller centers evaluated procedural volumes and reimbursement adequacy before expanding branched procedure offerings.

These tariff-related shifts also affected collaboration models between manufacturers and clinical partners. Investment in training programs and consignment-based stocking arrangements became more common as manufacturers sought to offset potential demand sensitivity by removing upfront acquisition barriers for facilities. At the same time, payers and hospital procurement committees increased scrutiny of total cost of care metrics, emphasizing long-term outcomes and device durability as central factors in purchasing decisions. Collectively, the tariff-driven adjustments in 2025 accelerated strategic re-alignment across sourcing, pricing, and partnership models within the branched thoracic stent graft ecosystem.

Comprehensive segmentation-driven insights that align graft architecture, material science, clinical indications, care settings, age demographics, and procedural delivery modes to decision-making

Segmentation offers a structured lens to interpret market dynamics and clinical decision drivers across device configurations, material science, clinical indications, care settings, patient demographics, and delivery strategies. Based on Device Type, the field is differentiated across Four Branched, Three Branched, and Two Branched graft architectures, each addressing distinct anatomic scenarios and procedural complexities. Four Branched devices cater to patients requiring comprehensive arch reconstruction with multiple branch revascularizations, whereas Three Branched and Two Branched designs are chosen for configurations that spare or bypass specific arch vessels while simplifying delivery and reducing procedural time.

Based on Graft Material, contemporary options include Dacron and ePTFE, with each material offering specific performance characteristics. Dacron is often valued for its long clinical track record and suture compatibility in hybrid constructs, while ePTFE is selected for its conformability and surface properties that may influence thrombogenicity and integration. Based on Application, clinical use cases split between Aortic Aneurysm and Aortic Dissection. The Aortic Aneurysm category is further considered as Thoracic Aneurysm and Thoracoabdominal Aneurysm, which differ in extent of visceral involvement and therefore in required device length and branch strategy. The Aortic Dissection category is further delineated into Type A and Type B, which carry distinct urgency profiles, anatomic repair targets, and implications for cerebral and visceral protection strategies.

Based on End-User, the procedural context spans Ambulatory Surgery Centers, Hospitals, and Specialty Clinics. Ambulatory Surgery Centers are further characterized by Hospital Owned and Independent models that influence capital access and case mix, while Hospitals are subdivided into Private and Public institutions that present different procurement cycles and payer interactions. Based on Patient Age Group, clinical pathways are analyzed across 18-45, 46-65, and 65+, each cohort presenting varying comorbidity burdens, anatomical considerations, and risk tolerance. Based on Delivery Mode, interventions are categorized as Endovascular and Hybrid approaches; endovascular solutions emphasize percutaneous access and modular deployment, whereas hybrid approaches integrate open surgical maneuvers with endovascular grafting to manage complex landing zones or provide cerebral protection. Synthesizing these segmentation perspectives enables targeted clinical strategies, differentiated product design priorities, and tailored commercial approaches that align with the nuanced needs of each subpopulation and care setting.

How regional differences in clinical capacity, regulatory pathways, purchasing models, and manufacturing ecosystems influence adoption and commercialization strategies

Regional variation fundamentally shapes adoption patterns, regulatory engagement, and commercial strategy for branched thoracic stent grafts. In the Americas, clinical communities in advanced tertiary centers have been early adopters of branched technologies, with multidisciplinary teams driving procedural refinement and outcomes reporting. Investment in imaging infrastructure and hybrid operating suites supports a concentration of complex cases in high-volume centers, while broader diffusion depends on training, reimbursement alignment, and supply chain reliability. The region's regulatory and payer environments influence device introduction timelines and the willingness of institutions to invest in newer device platforms.

Europe, Middle East & Africa presents a heterogeneous landscape where national regulatory pathways, hospital funding models, and practice patterns vary significantly. In some European markets, centralized procurement and health technology assessment frameworks necessitate robust clinical evidence and health economic justification for broader adoption. In the Middle East and Africa, demand is often concentrated in urban tertiary hospitals that serve as regional centers of excellence and that may facilitate rapid uptake of advanced device platforms when supported by skilled multidisciplinary teams.

Asia-Pacific encompasses markets with a wide spectrum of maturity in endovascular capabilities. Several markets within the region have active device development and manufacturing ecosystems, creating opportunities for localized production and cost-competitive offerings. Meanwhile, clinical adoption in major urban centers is supported by strong procedural volumes and growing investment in hybrid and endovascular operating rooms. Across all regions, regional collaboration, training initiatives, and registry participation play pivotal roles in harmonizing standards of care and accelerating responsible adoption of branched thoracic stent graft technology.

Strategic competitive approaches from innovators and established device manufacturers that combine engineering advances, evidence generation, and adaptable commercial models

The competitive environment for branched thoracic stent grafts is characterized by a mix of specialized innovators, established vascular device leaders, and emerging regional manufacturers. Key companies differentiate through focused investments in device engineering, such as low-profile delivery systems, pre-cannulated branch conduits, and modular architectures that accommodate patient-specific anatomy. Many leading players are also committing resources to post-market evidence generation, forming clinical partnerships and registry collaborations to demonstrate outcomes across diverse practice settings.

Strategic differentiators include integrated training programs that help clinicians shorten learning curves, consignment and leasing models that lower acquisition friction for hospitals, and bundled support services that encompass imaging optimization and procedural planning. Several companies are expanding their value proposition by offering digital tools for pre-operative planning, including patient-specific simulation and three-dimensional modeling, which increase procedural predictability and facilitate surgeon adoption. Moreover, manufacturing scale and supplier relationships are central to ensuring consistent device availability and cost control, particularly in the wake of supply chain pressures.

Emerging entrants and regional manufacturers are challenging incumbents on price and localized support, prompting established firms to highlight clinical outcomes, long-term durability, and comprehensive service offerings. Collaboration between industry and high-volume clinical centers continues to drive iterative product improvements and broaden indications. In this environment, the most successful companies will balance technical innovation with scalable service models, robust clinical evidence, and adaptable commercial strategies that respond to regional and institutional variability.

Practical strategic measures for manufacturers and providers to drive device innovation, secure supply continuity, and accelerate clinical adoption across care settings

Industry leaders should pursue integrated strategies that align product development, clinical partnerships, and commercial execution to accelerate responsible adoption while protecting margins and operational resilience. Prioritize investments in device design refinements that reduce profile and procedural complexity, as these attributes materially improve the addressable clinical population and facilitate broader uptake across care settings. Complement engineering improvements with robust clinician training programs and simulation-based curricula to shorten learning curves and reduce complication rates, thereby strengthening the clinical and economic case for adoption.

Mitigate supply chain and regulatory risks by diversifying suppliers, exploring localized manufacturing partnerships, and proactively engaging with regulatory authorities to align post-market data requirements. Where tariffs or trade policy create cost uncertainty, adopt flexible procurement models such as consignment inventory, leasing, or outcome-based contracting to preserve purchasing momentum among hospital systems and specialty centers. Strengthen evidence generation through multi-center registries and collaborative outcomes research that emphasize real-world safety and durability while addressing health economic questions relevant to payers.

Commercially, tailor go-to-market approaches to the segmentation dynamics described earlier: deploy focused strategies for Four Branched, Three Branched, and Two Branched device pathways; highlight material-specific benefits for Dacron and ePTFE grafts; and align messaging to end-user types including hospital-owned and independent ambulatory surgery centers. Finally, invest in digital planning tools and data analytics that support personalized device selection and demonstrate value to clinicians and procurement stakeholders. These combined actions will help industry leaders sustain innovation momentum while delivering predictable clinical and economic outcomes.

A mixed-methods research approach combining expert interviews, clinical literature synthesis, and regulatory evaluation to produce actionable insights for decision-makers

The research underpinning this analysis employed a mixed-methods approach combining primary qualitative interviews with key opinion leaders, device engineers, and procurement specialists, alongside secondary review of peer-reviewed clinical literature, procedural registries, and regulatory guidance documents. Primary data collection included structured interviews with vascular surgeons, interventional radiologists, and hospital administrators to capture procedural preferences, adoption barriers, and training needs. Technical interviews with manufacturing and supply chain experts informed assessments of material choices, component sourcing, and production scalability.

Secondary research focused on published clinical series, consensus statements, and guidance from major surgical societies to synthesize current standards of care and procedural best practices. Regulatory frameworks across major regions were examined to compare approval pathways, post-market surveillance expectations, and health technology assessment considerations. Where appropriate, case studies of procurement and implementation at leading centers were analyzed to identify operational enablers and common pitfalls.

Findings were triangulated across data sources to ensure consistency and to highlight areas of divergence. Emphasis was placed on evidence quality, clinical relevance, and operational applicability. Limitations of the methodology, such as the evolving nature of long-term outcome data and the variability of national reimbursement environments, were acknowledged and factored into the analysis. The resulting insights are intended to be actionable for strategic planners, clinical leaders, and commercial teams seeking to navigate the complex ecosystem surrounding branched thoracic stent graft adoption.

Concluding perspectives on how evidence, operational readiness, and adaptive strategies will determine the long-term integration and value realization of branched thoracic stent grafts

Branched thoracic stent grafts represent a pivotal advancement in the management of complex aortic disease, offering less invasive alternatives to open repair while expanding therapeutic options for anatomically challenging cases. The convergence of device innovation, enhanced imaging and navigation technologies, and accumulating clinical experience has catalyzed a shift in procedural paradigms and institutional strategies. However, adoption is contingent on demonstrable outcomes, reproducible training pathways, and supply chain stability that together underpin clinician confidence and payer acceptance.

Regional differences, material science considerations, and device architecture choices all influence clinical decision-making and commercial strategy. The combined impact of regulatory scrutiny, tariff dynamics, and evolving care delivery models demands that stakeholders adopt flexible, evidence-driven approaches. For manufacturers, this means investing in meaningful clinical partnerships and scalable manufacturing practices. For providers, it means carefully aligning procedural capabilities with institutional resources and patient selection priorities.

Ultimately, the trajectory of branched thoracic stent graft adoption will be shaped by the quality of long-term evidence, the effectiveness of training and planning tools to reduce procedural variability, and the ability of the ecosystem to adapt to policy and supply chain shocks. Stakeholders who integrate these elements into cohesive strategies will be best positioned to translate technological promise into consistent clinical value and sustainable program growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Branched Thoracic Stent Grafts Market, by Product Type

  • 8.1. Off-the-Shelf Branched Thoracic Stent Grafts
  • 8.2. Patient-Specific Branched Thoracic Stent Grafts
  • 8.3. Modular Branched Systems
  • 8.4. Hybrid Branched-Fenestrated Constructs

9. Branched Thoracic Stent Grafts Market, by Device Type

  • 9.1. Four Branched
  • 9.2. Three Branched
  • 9.3. Two Branched

10. Branched Thoracic Stent Grafts Market, by Graft Material

  • 10.1. Dacron
  • 10.2. Eptfe

11. Branched Thoracic Stent Grafts Market, by Delivery Mode

  • 11.1. Endovascular
  • 11.2. Hybrid

12. Branched Thoracic Stent Grafts Market, by Application

  • 12.1. Aortic Aneurysm
    • 12.1.1. Thoracic Aneurysm
    • 12.1.2. Thoracoabdominal Aneurysm
  • 12.2. Aortic Dissection
    • 12.2.1. Type A
    • 12.2.2. Type B

13. Branched Thoracic Stent Grafts Market, by End-User

  • 13.1. Ambulatory Surgery Centers
    • 13.1.1. Hospital Owned
    • 13.1.2. Independent
  • 13.2. Hospitals
    • 13.2.1. Private
    • 13.2.2. Public
  • 13.3. Specialty Clinics

14. Branched Thoracic Stent Grafts Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Branched Thoracic Stent Grafts Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Branched Thoracic Stent Grafts Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Branched Thoracic Stent Grafts Market

18. China Branched Thoracic Stent Grafts Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AorTech International PLC
  • 19.6. Aptus Endosystems, Inc.
  • 19.7. Atrium Medical Corporation
  • 19.8. Bolton Medical, Inc.
  • 19.9. Cardinal Health, Inc.
  • 19.10. Cook Medical LLC
  • 19.11. Cook Vascular
  • 19.12. CryoLife, Inc.
  • 19.13. Endospan Ltd.
  • 19.14. Endovascular Solutions, Inc.
  • 19.15. Getinge AB
  • 19.16. Hemoteq AG
  • 19.17. Innovative Cardiovascular Solutions, Inc.
  • 19.18. InspireMD Ltd.
  • 19.19. Jotec GmbH
  • 19.20. Medtronic plc
  • 19.21. MicroPort Scientific Corporation
  • 19.22. Nipro Corporation
  • 19.23. Pulsar Vascular Ltd.
  • 19.24. Terumo Corporation
  • 19.25. Vascutek Ltd.
  • 19.26. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY OFF-THE-SHELF BRANCHED THORACIC STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY OFF-THE-SHELF BRANCHED THORACIC STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY OFF-THE-SHELF BRANCHED THORACIC STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT-SPECIFIC BRANCHED THORACIC STENT GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT-SPECIFIC BRANCHED THORACIC STENT GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT-SPECIFIC BRANCHED THORACIC STENT GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY MODULAR BRANCHED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY MODULAR BRANCHED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY MODULAR BRANCHED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID BRANCHED-FENESTRATED CONSTRUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID BRANCHED-FENESTRATED CONSTRUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID BRANCHED-FENESTRATED CONSTRUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 192. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 225. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)